HUNTINGTON BEACH, Calif. – Soberlink Healthcare, the leader in remote alcohol monitoring technology, has partnered with The In-Home Addiction Treatment Institute (IHATI), a nonprofit organization dedicated to progressing the education, accessibility, and research of in-home substance use disorder treatment. Together, Soberlink and IHATI will study the outcomes of Alcohol Use Disorder clients using Soberlink alcohol monitoring in conjunction with the In-Home Addiction Treatment model of care.
For nearly 10 years, Soberlink has helped Treatment Providers stay connected to their clients’ recovery journeys. With Soberlink, clients submit a simple test from anywhere in the world, and Treatment Providers can instantly view their results from the convenience of their smart device. Soberlink’s purpose is to empower clients with accountability for their recovery and to provide early intervention opportunities to the care team.
The Soberlink/IHATI study launched on April 1st of this year, wherein 50 patients with an Alcohol Use Disorder will be treated by the In-Home Addiction Treatment model of care at Aware Recovery Care. At Aware Recovery Care, client outcomes already support the effectiveness of treating Alcohol Use Disorder in-home. Although Aware Recovery Care has used Soberlink to monitor their clients from the comfort of their own homes since 2015, this will be the first study that is IRB approved. The clients will use Soberlink for a 6-month testing period at a minimum of twice per day. The goal of the study is to document these clients’ outcomes based on their compliance with remote alcohol testing, recidivism, and quality of life surveys.
The Soberlink device utilizes facial recognition technology and sends real-time results to the client’s care team when a patient misses a scheduled test, or when the patient tests positive for alcohol use. With this information, the care teams can inform the community providers and support systems if a patient is at an elevated risk for relapse or has returned to alcohol use. Ultimately, this data is designed to improve clinical outcomes and manage financial risk by facilitating early interventions and other means of mitigating recidivism as well as other costly treatment episodes.
The ability to assess risk and inform care via remote, real-time breathalyzer results such as those managed by Aware Recovery Care is new to the addiction treatment space. “We are enthused to partner with The In-Home Addiction Treatment Institute and Aware Recovery Care to show the efficacy of new innovative ways to treat clients struggling with alcohol use disorders from the comfort of their own homes,” says Andy Rothman, VP of Business Development. “We are very excited to see actionable data from our devices utilized by clients receiving in-home alcohol use disorder treatment to improve outcomes.”
Soberlink supports accountability for sobriety through a comprehensive alcohol monitoring system. Combining a professional-grade breathalyzer with wireless connectivity, the portable design and state-of-the-art technology includes facial recognition, tamper detection and real-time results sent to designated individuals. With FDA 510(k) medical clearance, Soberlink is the trusted tool in addiction recovery, workplace compliance and family law. Soberlink documents sobriety with a high level of reliability and accuracy to foster trust and peace of mind.
About In-Home Addiction Treatment Institute
In-Home Addiction Treatment was developed and first delivered at Aware Recovery Care. Being a new model of substance use disorder treatment, there is much research needed around the model to determine efficacy and identify enhancements to the current modalities used within the model. IHATI specializes in educating practitioners and evaluating treatment outcomes. Research, in conjunction with improving education about the model and role of a practitioner within it, is required to offer this innovative form of treatment to a wider audience. In 2013, the Substance Abuse and Mental Health Services Administration reported that of the 22.7 million Americans suffering with substance use disorder, only 2.5 million accessed treatment. Considering this demonstrated treatment gap and the growing severity of the opioid crisis, it is essential that new treatment methods such as the IHAT model are advanced through research and educational efforts. For more information, visit www.ihatinstitute.org.